Anavex Life Sciences Corp (AVXL)

[georgejjl]

Targeted therapy for Alzheimer's treatment. If Anavex 2-73 can be successful in just 20% of the 5 million Alzheimer's patients in the USA, then that is possibly over a million patients and their families that will benefit.

- Systemic analysis using KEM® identifies actionable parameters enabling a precision medicine approach to include best responders in follow-up Phase 2/3 study

§ Additional data to be incorporated

- DNA, RNA and gut microbiota
- Advanced data analytics will enable “targeted therapy” design for new trial

http://www.anavex.com/my_uploads/ANAVEX2-73-PKPD-Phase-2a-2017.pdf

Good luck and GOD bless,

George